Trials
Search / Trial NCT06424990

Balance Training With TENS for Spastic Diplegic Cerebral Palsy

Launched by CAIRO UNIVERSITY · May 17, 2024

Trial Information

Current as of February 19, 2025

Completed

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • A diagnosis of spastic diplegia cerebral palsy.
  • Age from 10 to 12 years.
  • Spasticity grade 1 and 1+ according to the Modified Ashworth scale.
  • Level II motor function according to the Growth Motor Function Classification System.
  • Able to understand and follow instructions.
  • Their heights are more than 100 cm and weights are more than 20 Kg which are the lower limits of height and weight needed by the Biodex stability system.
  • Exclusion Criteria:
  • Epilepsy.
  • Significant visual or auditory problems according to medical reports (audio-vestibular and ophthalmic examination).
  • Structural or fixed soft tissue deformities of the lower extremities.
  • Neurological or orthopedic surgery in the past 12 months.
  • Botox injection in the lower extremities in the past 6 months.
  • Fracture, sprain, or strain injury of the lower extremities in the past 6 months.

About Cairo University

Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.

Locations

Giza, , Egypt

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0